Hello and welcome to Sigma Nutrition Radio.

I am your host, Danny Lennon.

And today we're going to be talking about an extremely interesting but also incredibly

important set of topics that have came on my radar

recently thanks to today's guest, Dr. Austin Baraki, who has been incredibly helpful and informative

to me about highlighting some of the issues we're going to explore today and just how critically important they are and getting me exposed to some of the issues we're going to explore today and just how critically

important they are and getting me exposed to some of the literature in this area that's

really really interesting so dr austin baraki is an internal medicine physician based in san

ntonio texas today's topic is one that he's personally very passionate about.

And recently he made me aware of some of the potential pitfalls and harms that can occur

from things that are sometimes seemingly innocuous, or at least that were oblivious to,

related to direct to consumer testing, for example,

of various different biomarkers and measures.

And this opened up a whole field related to what screening is, how it can be used appropriately

in medical settings and otherwise, and then other related concepts around over diagnosis, over treatment, over medicalization.

And there's so much to work through here.

And this conversation is one that I know many of you are going to find really, really interesting.

And Dr. Bracki has an amazing way of breaking many of these concepts down and walking through how important they are, but also explaining them, as I'm sure you'll see throughout this conversation.

So I hope this conversation proves useful in highlighting to you potential issues around inappropriate screening

or too much screening, particularly of asymptomatic healthy people, but also in cases where there are symptoms.

And then these broader issues around over diagnosis and over treatment,

and been able to understand these and really keep this at the forefront of your mind,

...